The Current Status, Trend, and Development Strategies of Chinese Biopharmaceutical Industry With a Challenging Perspective

Kerong Zhang,Wuyi Liu

doi:10.1177/2158244020901529

Abstract

Biopharmaceutical technology is one of the most promising biotechnologies in the world. With the development of modern biotechnology, biopharmaceuticals are thriving and developing rapidly as a global high-tech biotechnology industry, bringing the unprecedented market prospects to biopharmaceuticals in China and the world. Today, world is witnessing that Chinese biopharmaceutical industry is booming and growing up. The national biopharmaceutical industry of China, especially the development and industrialization of biological medicines with genetic engineering drugs as its core fields, has already reached a certain market scale after over 20 years of development. The biopharmaceutical industry will be one of the most active economic sectors in China, whereas the biotechnological revolution with modern biopharmaceutical technology has become the lifeblood of maintaining human health and food safety in the future. The article systematically analyzed and evaluated the current status and trend and explored the main existing problems of Chinese biopharmaceutical industry with some development strategies in a challenging perspective. It probes into Chinese biopharmaceutical industry and its bases too. The future development prospects of Chinese national biopharmaceutical industry are much optimistic but challenging.

Highlights

There are generally two composite concepts of the biopharmaceutical industry in the broad and narrow definitions (Walsh, 2001, 2014)
There are presently more than 200 biopharmaceutical technology companies officially registered in China, and many of them have obtained approvals for trial production or production of genetic engineering drugs, which are distributed throughout the country
There are more than 200 biopharmaceutical technology companies officially registered in China, and many of them have obtained approvals for trial production or production of genetic engineering drugs, which are distributed throughout the country

Summary

Introduction

There are generally two composite concepts of the biopharmaceutical industry in the broad and narrow definitions (Walsh, 2001, 2014). The broadly defined “biopharmaceutical industry” refers to a class of enterprises or companies engaged in similar business to make products for prevention, treatment, diagnosis, and other uses in pharmacy. The narrowly defined “biopharmaceutical industry” is the biomedical products for the prevention, diagnosis, and treatment of human diseases. The most important technology applied in biopharmaceutical industry is genetic engineering technology, which uses cloning technology and tissue culture technology to cut, insert, link, and recombine DNA fragments to gain useful biopharmaceutical products. Biopharmaceutical products mainly include three major categories, that is, genetic engineering drugs, biological vaccines, and biological diagnostic agents, that play an important role in the diagnosis, prevention, control, and eradication of infectious diseases to protect and extend human health and longevity

Objectives

Findings

Conclusion